Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequency
Wan-Ching Yen(OncoMed (United States)), Timothy Hoey, John Lewicki(OncoMed (United States)), Marcus Fischer(St. Jude Children's Research Hospital), Janak Raval(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), Fumiko Axelrod(OncoMed (United States)), Chris Bond(OncoMed (United States)), Shirley Ma(University of Maryland Center for Environmental Science), Jalpa Shah(OncoMed (United States)), Cécile Chartier(Io Therapeutics (United States)), Austin Gurney(Australian Centre for Heart Health), René Meisner(OncoMed (United States))
Cited by 1
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
|Journal of Biological Chemistry|2001|410